BUILDING PATHWAYS TO PATIENTS 

FOR INFORMATION ON COVID-19 TESTS PLEASE CLICK BELOW

US FDA Approves ARAKODA (tafenoquine) tablets for oral use, first preventative antimalarial approved in almost two decades

21st August, 2018

                               CONTACT US

For help or more information,  please don't hesitate to contacts us:

Registered Australian Office:

Biocelect Pty Ltd

Level 4, 51 Rawson Street, Epping NSW 2121, Australia

Registered New Zealand Office:

Biocelect New Zealand Limited

Level 5, Wynn Williams House, 47 Hereford Street, Christchurch 8013, New Zealand

General Inquiries: 1300 907 411 

To report a suspected side effect by a Biocelect
Pharmaceutical Drug or Vaccine: 1300 848 628

  • LinkedIn Social Icon
Biocelect Logo_Colour.png

Copyright 2019 Biocelect 

Australian Office: Suite 502, 139 Macquarie Street, Sydney NSW 2000, Australia

Registered Office Australia: Suite 405, Level 4, 51 Rawson Street, Epping NSW, 2121,  Australia 

Registered Office New Zealand: Level 5, Wynn Williams House, 47 Hereford Street, Christchurch 8013, New Zealand

Biocelect acknowledges the Traditional Custodians of Australia and their continued connection to land,

sea and community. We pay our respects to the Elders, past and present. 

Privacy Policy

  • LinkedIn Social Icon